Literature DB >> 26969587

Identification of key research needs for topical therapy treatment of psoriasis - a consensus paper by the International Psoriasis Council.

J J Wu1, C W Lynde2, C E Kleyn3, L Iversen4, J M van der Walt5, A Carvalho6, B Kirby7, R Bissonnette8.   

Abstract

In this age of expanding choices of therapy for psoriasis, topical therapies still play an important part in the management of patients. There are many knowledge gaps in topical therapy for psoriasis with regard to efficacy and safety as well as various combinations including topical therapy with phototherapy or with systemic agents. Councillors of the International Psoriasis Council comprised a topical therapy working group to describe these gaps in order to help direct future research endeavours. Herein, we present the results of this analysis, discuss topical agents in clinical development and the attributes of the ideal topical treatment for psoriasis.
© 2016 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26969587     DOI: 10.1111/jdv.13614

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

1.  Topical heat shock protein 70 prevents imiquimod-induced psoriasis-like inflammation in mice.

Authors:  Federico G Seifarth; Julia E-M Lax; Jennifer Harvey; Paul E DiCorleto; M Elaine Husni; Unnikrishnan M Chandrasekharan; Michael Tytell
Journal:  Cell Stress Chaperones       Date:  2018-04-03       Impact factor: 3.667

Review 2.  Epidermal mTORC1 Signaling Contributes to the Pathogenesis of Psoriasis and Could Serve as a Therapeutic Target.

Authors:  Claudia Buerger
Journal:  Front Immunol       Date:  2018-11-30       Impact factor: 7.561

3.  Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open-label randomized comparative pilot clinical study.

Authors:  P Alex; S Williams; L Sutton; T Yesudas; C Sutton; S Thomas; M Centola
Journal:  Clin Exp Dermatol       Date:  2019-09-26       Impact factor: 3.470

4.  Celastrol Niosome Hydrogel Has Anti-Inflammatory Effect on Skin Keratinocytes and Circulation without Systemic Drug Exposure in Psoriasis Mice.

Authors:  Fen Qiu; Long Xi; Shengshuang Chen; Yonghua Zhao; Zhenping Wang; Ying Zheng
Journal:  Int J Nanomedicine       Date:  2021-09-04

5.  A Six-Year Analysis of Biological Therapy for Severe Psoriasis in a Lithuanian Reference Centre of Dermatovenereology.

Authors:  Tadas Raudonis; Akvile Gliebute; Anna Greta Grigaityte; Zivile Lukosiunaite; Tatjana Karmaziene; Jurate Grigaitiene
Journal:  Medicina (Kaunas)       Date:  2020-06-04       Impact factor: 2.430

6.  Topical application of an amygdalin analogue reduces inflammation and keratinocyte proliferation in a psoriasis mouse model.

Authors:  Nuria Gago-López; Carmen Lagunas Arnal; Juan J Perez; Erwin F Wagner
Journal:  Exp Dermatol       Date:  2021-05-28       Impact factor: 3.960

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.